News

How To Earn $500 A Month From Johnson & Johnson Stock

On Tuesday, Johnson & Johnson (NYSE:JNJ) announced results from the open-label Phase 2 SKIPPirr study, which evaluated additional prophylactic strategies to reduce the incidence of infusion-related reactions (IRRs) with intravenous (IV) Rybrevant (amivantamab-vmjw) in patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions (ex19del) or L858R substitution mutations. The company, last month, agreed to acquire V-Wave for an upfront pa

U.S. Bancorp’s Lagging Stock Puts Onus on Investor Day

(Bloomberg) -- As U.S. Bancorp holds its first Investor Day in five years on Thursday, investors will be listening for clues about how one of the biggest US lenders can turn its lackluster stock around.Most Read from BloombergHow Americans Voted Their Way Into a Housing CrisisFor Tenants, AI-Powered Screening Can Be a New Barrier to HousingHousing’s Worst Crisis in Decades Reverberates Through 2024 RaceAfter a Record Hot Summer, Pressure Grows for A/C MandatesChicago Halts Hiring as Deficit Tops